A detailed history of Nicolet Advisory Services, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nicolet Advisory Services, LLC holds 32,768 shares of ABT stock, worth $3.74 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
32,768
Previous 30,601 7.08%
Holding current value
$3.74 Million
Previous $3.18 Million 17.49%
% of portfolio
0.35%
Previous 0.32%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $216,851 - $255,987
2,167 Added 7.08%
32,768 $3.74 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $45,127 - $50,373
448 Added 1.49%
30,601 $3.18 Million
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $63,850 - $70,519
583 Added 1.97%
30,153 $3.43 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $640,619 - $784,171
-7,103 Reduced 19.37%
29,570 $3.25 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $315,917 - $379,048
3,307 Added 9.91%
36,673 $3.55 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $286,719 - $319,465
2,845 Added 9.32%
33,366 $3.64 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $1 Million - $1.18 Million
10,356 Added 51.36%
30,521 $3.09 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $998,034 - $1.17 Million
10,499 Added 108.62%
20,165 $2.21 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $196,713 - $227,756
2,033 Added 26.63%
9,666 $977,000
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $13,167 - $15,914
129 Added 1.72%
7,633 $836,000
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $29,873 - $36,428
262 Added 3.62%
7,504 $925,000
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $159,546 - $195,356
-1,381 Reduced 16.02%
7,242 $1.02 Million
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $204,271 - $225,984
1,751 Added 25.48%
8,623 $1.02 Million
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $63,050 - $74,219
-596 Reduced 7.98%
6,872 $797,000
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $59,862 - $70,526
-550 Reduced 6.86%
7,468 $895,000
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $42,210 - $45,996
402 Added 5.28%
8,018 $878,000
Q3 2020

Oct 27, 2020

SELL
$91.64 - $111.29 $435,015 - $528,293
-4,747 Reduced 38.4%
7,616 $829,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $1,990 - $2,548
26 Added 0.21%
12,363 $1.13 Million
Q1 2020

Apr 21, 2020

BUY
$62.82 - $91.86 $290,605 - $424,944
4,626 Added 59.99%
12,337 $974,000
Q4 2019

Jan 23, 2020

BUY
$78.51 - $87.4 $1,491 - $1,660
19 Added 0.25%
7,711 $670,000
Q3 2019

Oct 22, 2019

BUY
$81.84 - $88.74 $163 - $177
2 Added 0.03%
7,692 $644,000
Q2 2019

Jul 26, 2019

SELL
$72.88 - $85.0 $13,992 - $16,320
-192 Reduced 2.44%
7,690 $647,000
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $521,946 - $631,032
7,882 New
7,882 $630,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nicolet Advisory Services, LLC Portfolio

Follow Nicolet Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Advisory Services, LLC with notifications on news.